|
|
Suppliers for CAS
851113-28-5
|
Properties | CAS |
851113-28-5 |
|
2 Registered suppliers
BOC Sciences
USA
Description : The thieno[3,4-d]imidazol-4-yl moiety embedded within this newly synthesized compound harbors the potential for therapeutic utility against neurological disorders. However, its intricate structure demands rigorous evaluation of its safety and efficacy as a potential drug prior to clinical translation. Despite preliminary implications, extensive studies are necessary to determine the full scope of its therapeutic potential. Molecular Formula : C30H47N5O5S Canonical SMILES : C1C2C(C(S1)CCCCC(=O)NCCCCCC(=O)NCCCCCC(=O)NCCC3=CC=C(C=C3)O)NC(=O)N2 InChI : InChI=1S/C30H47N5O5S/c36-23-15-13-22(14-16-23)17-20-33-28(39)11-4-2-8-18-31-26(37)10-3-1-7-19-32-27(38)12-6-5-9-25-29-24(21-41-25)34-30(40)35-29/h13-16,24-25,29,36H,1-12,17-21H2,(H,31,37)(H,32,38)(H,33,39)(H2,34,35,40)/t24-,25-,29-/m0/s1 InChIKey : AONIROLXOSTVPV-QEMZJVQQSA-N Synonyms : N-(4-Hydroxyphenethyl)-6-(6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanamido)hexanamide; Biotin-Ahx-Ahx-Tyramide
More details are to be found here
Iris Biotech GmbH
Germany
Formula: C30H47N5O5S Mol Weight: 589,8g/mol Synonym: Biotin-XX-Phenol, N-(4-hydroxyphenethyl)-6-(6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanamido)hexanamide
More details are to be found here
|
|
|
Privileged suppliers
Last update 2024-04-29
|